Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Analytical Chemistry"
DOI: 10.1155/2020/7290470
Abstract: Lusutrombopag is a second oral thrombopoietin (TPO) receptor agonist that selectively acts on human TPO receptors. In the study, UPLC-MS/MS was used to establish a selective and sensitive method to determine lusutrombopag with poziotinib as… read more here.
Keywords: receptor agonist; thrombopoietin; lusutrombopag poziotinib; lusutrombopag ... See more keywords